Schnieders Capital Management LLC Organon & Co. Transaction History

Schnieders Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$31.66 - $38.9 $325,686 - $400,164	-10,287 Closed	0 $0
Q1 2022 Apr 27, 2022	SELL	$30.45 - $39.36 $548 - $708	-18 Reduced 0.17%	10,287 $359,000
Q4 2021 Feb 03, 2022	BUY	$28.67 - $37.13 $75,717 - $98,060	2,641 Added 34.46%	10,305 $314,000
Q3 2021 Nov 01, 2021	BUY	$28.63 - $35.64 $219,420 - $273,144	7,664 New	7,664 $251,000

795

191M

1.59M

931K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.87B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Schnieders Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Schnieders Capital Management LLC with notifications on news.